Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zinc Calcite is a pharmaceutical combination of **calcium gluconate** and **zinc gluconate**, primarily utilized in China for pediatric nutritional support. It is specifically indicated for the treatment and prevention of calcium and zinc deficiencies, which can manifest as growth retardation, anorexia, and weakened immunity in children. Calcium is a vital mineral for bone development and neuromuscular function, while zinc serves as an essential cofactor for over 300 enzymes involved in DNA synthesis, protein metabolism, and cell division. The drug is typically formulated as an oral solution to improve compliance in pediatric populations. A Phase 4 real-world study (ChiCTR2500099734) is currently evaluating its efficacy and safety in children aged 3 to 10 years with growth retardation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium gluconate + zinc gluconate.